$CSC FY15 10-K: Cash provided by operating activities was $1,433MM vs. $1,560MM during FY14. Cash used in investing activities was $536MM vs. $566MM during FY14. Cash used in financing activities was $1,038MM vs. $599MM during FY14. Free cash flow was $717MM vs. $689MM in FY14. DSO was 71 at April 3, 2015.
$FTR reorganized its business structure with the creation of new consumer and commercial business. The company said that the previous structures were more regionally focused and it had seven regions structure before the reorganization.
$PCLN believes that over the next decade China will continue to be
one of the largest opportunities for travel growth in terms of increasing market
share for the company. $PCLN also sees opportunities to increase domestic market
share in the US.
$PRGO said that in the Consumer Healthcare business, it has been seeing certain pricing pressure. Therefore, across categories $PRGO competes in, it has competitive pricing. The company expects pricing pressure to continue in different segments going forward. But given the growth in new products, $PRGO expects to overcome the pricing challenges.